Header Logo
Last Name


InstitutionMD Anderson
Address7777 Knight Rd
Houston TX 77054-3005
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yan J, Kong LY, Hu J, Gabrusiewicz K, Dibra D, Xia X, Heimberger AB, Li S. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. J Natl Cancer Inst. 2015 Aug; 107(8). PMID: 25971300.
      View in: PubMed
    2. Mitra A, Satelli A, Xia X, Cutrera J, Mishra L, Li S. Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers. Int J Cancer. 2015 Jul 15; 137(2):491-6. PMID: 25487874; PMCID: PMC4429009.
    3. Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman MJ, Kopetz S, Ellis LM, Meng QH, Li S. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015 Feb 15; 21(4):899-906. PMID: 25516888; PMCID: PMC4334736.
    4. Mitra A, Satelli A, Yan J, Xueqing X, Gagea M, Hunter CA, Mishra L, Li S. IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice. Hepatology. 2014 Dec; 60(6):2027-39. PMID: 25351459; PMCID: PMC4245364.
    5. Dibra D, Mishra L, Li S. Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship. Biochim Biophys Acta. 2014 Aug; 1846(1):152-60. PMID: 24821201; PMCID: PMC4140981.
    6. Wang X, Li S. Protein mislocalization: mechanisms, functions and clinical applications in cancer. Biochim Biophys Acta. 2014 Aug; 1846(1):13-25. PMID: 24709009; PMCID: PMC4141035.
    7. Hu J, Zhu S, Xia X, Zhang L, Kleinerman ES, Li S. CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Mol Cancer. 2014 Feb 24; 13:34. PMID: 24565056; PMCID: PMC3938086.
    8. Satelli A, Mitra A, Cutrera JJ, Devarie M, Xia X, Ingram DR, Dibra D, Somaiah N, Torres KE, Ravi V, Ludwig JA, Kleinerman ES, Li S. Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res. 2014 Mar 15; 74(6):1645-50. PMID: 24448245; PMCID: PMC3959622.
    9. Hu J, Cutrera J, Li S. The impact of non-electrical factors on electrical gene transfer. Methods Mol Biol. 2014; 1121:47-54. PMID: 24510810; PMCID: PMC4116183.
    10. Cutrera J, King G, Jones P, Gumpel E, Xia X, Li S. Managing local swelling following intratumoral electro-chemo-gene therapy. Methods Mol Biol. 2014; 1121:233-9. PMID: 24510827; PMCID: PMC4098855.
    11. Hu J, Li S. Electroporation formulation for cell therapy. Methods Mol Biol. 2014; 1121:55-60. PMID: 24510811; PMCID: PMC4116184.
    12. Dibra D, Li S. The cell-to-cell coordination between activated T cells and CpG-stimulated macrophages synergistically induce elevated levels of IL-10 via NF-?B1, STAT3, and CD40/CD154. Cell Commun Signal. 2013 Dec 13; 11:95. PMID: 24330710; PMCID: PMC3880105.
    13. Cutrera J, Dibra D, Satelli A, Xia X, Li S. Intricacies for posttranslational tumor-targeted cytokine gene therapy. Mediators Inflamm. 2013; 2013:378971. PMID: 24369443; PMCID: PMC3863455.
    14. Fang RH, Hu CM, Chen KN, Luk BT, Carpenter CW, Gao W, Li S, Zhang DE, Lu W, Zhang L. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale. 2013 Oct 07; 5(19):8884-8. PMID: 23907698; PMCID: PMC3831007.
    15. Irwin ME, Nelson LD, Santiago-O'Farrill JM, Knouse PD, Miller CP, Palla SL, Siwak DR, Mills GB, Estrov Z, Li S, Kornblau SM, Hughes DP, Chandra J. Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia. PLoS One. 2013; 8(8):e70608. PMID: 23936456; PMCID: PMC3731286.
    16. Mitra A, Mishra L, Li S. Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol. 2013 Jun; 31(6):347-54. PMID: 23597659; PMCID: PMC3665643.
    17. Liu Z, Liu JQ, Talebian F, Wu LC, Li S, Bai XF. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol. 2013 Feb; 43(2):468-79. PMID: 23225163; PMCID: PMC3625660.
    18. Cutrera J, Johnson B, Ellis L, Li S. Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies. Cancer Lett. 2013 Feb 01; 329(1):68-73. PMID: 23111105; PMCID: PMC3535523.
    19. Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR, Li S, Katz L, Farci P, Mishra L. Hepatic stem cells and transforming growth factor ß in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2012 Sep; 9(9):530-8. PMID: 22710573; PMCID: PMC3745216.
    20. Flanagan M, Gimble JM, Yu G, Xia X, Bunnell BA, Li S. Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells. Biol Proced Online. 2012 Apr 18; 14(1):7. PMID: 22512891.
      View in: PubMed
    21. Dibra D, Cutrera JJ, Li S. Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30. J Immunol. 2012 Apr 15; 188(8):3709-15. PMID: 22407920; PMCID: PMC3324657.
    22. Dibra D, Cutrera J, Xia X, Kallakury B, Mishra L, Li S. Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology. 2012 Apr; 55(4):1204-14. PMID: 22105582; PMCID: PMC3295919.
    23. Zolochevska O, Xia X, Williams BJ, Ramsay A, Li S, Figueiredo ML. Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum Gene Ther. 2011 Dec; 22(12):1537-50. PMID: 21801027.
      View in: PubMed
    24. Hu J, Liu X, Hughes D, Esteva FJ, Liu B, Chandra J, Li S. Herceptin conjugates linked by EDC boost direct tumor cell death via programmed tumor cell necrosis. PLoS One. 2011; 6(8):e23270. PMID: 21853100; PMCID: PMC3154407.
    25. Flanagan M, Gimble JM, Yu G, Wu X, Xia X, Hu J, Yao S, Li S. Competitive electroporation formulation for cell therapy. Cancer Gene Ther. 2011 Aug; 18(8):579-86. PMID: 21660061; PMCID: PMC3238913.
    26. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011 Sep; 68(18):3033-46. PMID: 21637948; PMCID: PMC3162105.
    27. Dibra D, Cutrera J, Xia X, Li S. WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells. PLoS One. 2011 Apr 29; 6(4):e19072. PMID: 21559505; PMCID: PMC3084744.
    28. Cutrera J, Dibra D, Xia X, Hasan A, Reed S, Li S. Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy. Mol Ther. 2011 Aug; 19(8):1468-77. PMID: 21386825; PMCID: PMC3149172.
    29. Li S. Biological Procedures Online now publishing with BioMed Central. Biol Proced Online. 2011 Jan 31; 13:2. PMID: 21369533; PMCID: PMC3047433.
    30. Reed SD, Li S. Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy. Cancer Gene Ther. 2011 Apr; 18(4):265-74. PMID: 21233859; PMCID: PMC3415231.
    31. Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, Li S. Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Ther. 2010 Aug; 17(8):571-8. PMID: 20414325.
      View in: PubMed
    32. Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, Li S. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Ther. 2010 Jul; 17(7):457-64. PMID: 20150931; PMCID: PMC3148143.
    33. Zhu S, Lee DA, Li S. IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol. 2010 Mar 01; 184(5):2348-54. PMID: 20139275; PMCID: PMC2824785.
    34. Li S. The possible cellular mechanism for extending lifespan of mice with rapamycin. Biol Proced Online. 2009 Sep 01; 11:1-2. PMID: 19728006; PMCID: PMC3056009.
    35. Cutrera J, Dibra D, Xia X, Li S. Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences. Cancer Gene Ther. 2010 Feb; 17(2):131-40. PMID: 19713998; PMCID: PMC2808434.
    36. Reed SD, Li S. Electroporation advances in large animals. Curr Gene Ther. 2009 Aug; 9(4):316-26. PMID: 19545229.
      View in: PubMed
    37. Dibra D, Cutrera JJ, Xia X, Birkenbach MP, Li S. Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. Cancer Res. 2009 Jul 01; 69(13):5505-13. PMID: 19549909; PMCID: PMC2706921.
    38. Shiomitsu K, Sajo E, Xia X, Hunley DW, Mauldin GE, Li S, Mauldin GN. Radiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro. Vet Comp Oncol. 2008 Sep; 6(3):193-200. PMID: 19178679.
      View in: PubMed
    39. Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li S. Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors. Mol Ther. 2008 May; 16(5):901-6. PMID: 18388923.
      View in: PubMed
    40. Cutrera J, Torrero M, Shiomitsu K, Mauldin N, Li S. Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs. Methods Mol Biol. 2008; 423:319-25. PMID: 18370210.
      View in: PubMed
    41. Torrero M, Li S. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination. Methods Mol Biol. 2008; 423:339-49. PMID: 18370212.
      View in: PubMed
    42. Li S. Electroporation gene therapy. Preface. Methods Mol Biol. 2008; 423:v-vii. PMID: 18453074.
      View in: PubMed
    43. Li S. Delivery of DNA into tumors. Methods Mol Biol. 2008; 423:311-8. PMID: 18370209.
      View in: PubMed
    44. Zhu S, Li S. Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation. Methods Mol Biol. 2008; 423:327-37. PMID: 18370211.
      View in: PubMed
    45. Zhu S, Waguespack M, Barker SA, Li S. Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect. Clin Cancer Res. 2007 Jul 15; 13(14):4252-60. PMID: 17634555.
      View in: PubMed
    46. Liu J, Xia X, Torrero M, Barrett R, Shillitoe EJ, Li S. The mechanism of exogenous B7.1-enhanced IL-12-mediated complete regression of tumors by a single electroporation delivery. Int J Cancer. 2006 Nov 01; 119(9):2113-8. PMID: 16823840.
      View in: PubMed
    47. Craig R, Li S. Function and molecular mechanism of tumor-targeted peptides for delivering therapeutic genes and chemical drugs. Mini Rev Med Chem. 2006 Jul; 6(7):757-64. PMID: 16842125.
      View in: PubMed
    48. Torrero MN, Xia X, Henk W, Yu S, Li S. Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression. Cancer Res. 2006 Apr 15; 66(8):4461-7. PMID: 16618773.
      View in: PubMed
    49. Torrero MN, Henk WG, Li S. Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy. Clin Cancer Res. 2006 Jan 01; 12(1):257-63. PMID: 16397050.
      View in: PubMed
    50. Li S, Zhang L, Torrero M, Cannon M, Barret R. Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer. Mol Ther. 2005 Nov; 12(5):942-9. PMID: 15953768.
      View in: PubMed
    51. Li S, Wilkinson M, Xia X, David M, Xu L, Purkel-Sutton A, Bhardwaj A. Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. Mol Ther. 2005 Jan; 11(1):112-9. PMID: 15585412.
      View in: PubMed
    52. Li S. Electroporation gene therapy: new developments in vivo and in vitro. Curr Gene Ther. 2004 Sep; 4(3):309-16. PMID: 15384944.
      View in: PubMed
    53. Li S, Hanna E, Breau R, Ratanatharathorn V, Xia X, Suen J. Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs. Br J Cancer. 2004 Mar 08; 90(5):1093-9. PMID: 14997212; PMCID: PMC2409636.
    54. Li S, Xia X, Mellieon FM, Liu J, Steele S. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy. Mol Ther. 2004 Mar; 9(3):347-54. PMID: 15006601.
      View in: PubMed
    55. Dornhoffer JL, Danner C, Zhou L, Li S. Atrial natriuretic peptide receptor upregulation in the rat inner ear. Ann Otol Rhinol Laryngol. 2002 Nov; 111(11):1040-4. PMID: 12450181.
      View in: PubMed
    56. Wang J, Hamilton JI, Carter MS, Li S, Wilkinson MF. Alternatively spliced TCR mRNA induced by disruption of reading frame. Science. 2002 Jul 05; 297(5578):108-10. PMID: 12098701.
      View in: PubMed
    57. Pumphrey CY, Theus AM, Li S, Parrish RS, Sanderson RD. Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res. 2002 Jul 01; 62(13):3722-8. PMID: 12097281.
      View in: PubMed
    58. Li S, Zhang X, Xia X. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy. J Natl Cancer Inst. 2002 May 15; 94(10):762-8. PMID: 12011227.
      View in: PubMed
    59. Dornhoffer JL, Danner C, Li S. Natriuretic peptide receptors in the human endolymphatic sac. Arch Otolaryngol Head Neck Surg. 2002 Apr; 128(4):379-83. PMID: 11926910.
      View in: PubMed
    60. Li S, Xia X, Zhang X, Suen J. Regression of tumors by IFN-alpha electroporation gene therapy and analysis of the responsible genes by cDNA array. Gene Ther. 2002 Mar; 9(6):390-7. PMID: 11960315.
      View in: PubMed
    61. Li S, Benninger M. Applications of muscle electroporation gene therapy. Curr Gene Ther. 2002 Feb; 2(1):101-5. PMID: 12108971.
      View in: PubMed
    62. Mühlemann O, Mock-Casagrande CS, Wang J, Li S, Custódio N, Carmo-Fonseca M, Wilkinson MF, Moore MJ. Precursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol Cell. 2001 Jul; 8(1):33-43. PMID: 11511358.
      View in: PubMed
    63. Hanna E, Shrieve DC, Ratanatharathorn V, Xia X, Breau R, Suen J, Li S. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res. 2001 Mar 15; 61(6):2376-80. PMID: 11289099.
      View in: PubMed
    64. Li S, Zhang X, Xia X, Zhou L, Breau R, Suen J, Hanna E. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site. Gene Ther. 2001 Mar; 8(5):400-7. PMID: 11313817.
      View in: PubMed
    65. Hanna E, Zhang X, Woodlis J, Breau R, Suen J, Li S. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther. 2001 Mar; 8(3):151-7. PMID: 11332985.
      View in: PubMed
    66. Li S, MacLaughlin FC, Fewell JG, Gondo M, Wang J, Nicol F, Dean DA, Smith LC. Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid. Gene Ther. 2001 Mar; 8(6):494-7. PMID: 11313829.
      View in: PubMed
    67. Li S, MacLaughlin FC, Fewell JG, Li Y, Mehta V, French MF, Nordstrom JL, Coleman M, Belagali NS, Schwartz RJ, Smith LC. Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems. Gene Ther. 1999 Dec; 6(12):2005-11. PMID: 10637452.
      View in: PubMed
    68. Li S, Wilkinson MF. Nonsense surveillance in lymphocytes? Immunity. 1998 Feb; 8(2):135-41. PMID: 9491995.
      View in: PubMed
    69. Li S, Wilkinson MF. Site-directed mutagenesis: a two-step method using PCR and DpnI. Biotechniques. 1997 Oct; 23(4):588-90. PMID: 9343667.
      View in: PubMed
    70. Li S, Leonard D, Wilkinson MF. T cell receptor (TCR) mini-gene mRNA expression regulated by nonsense codons: a nuclear-associated translation-like mechanism. J Exp Med. 1997 Mar 17; 185(6):985-92. PMID: 9091590; PMCID: PMC2196228.
    71. Li S, Ke S, Budde RJ. The C-terminal Src kinase (Csk) is widely expressed, active in HT-29 cells that contain activated Src, and its expression is downregulated in butyrate-treated SW620 cells. Cell Biol Int. 1996 Nov; 20(11):723-9. PMID: 8979366.
      View in: PubMed
    72. Carter MS, Li S, Wilkinson MF. A splicing-dependent regulatory mechanism that detects translation signals. EMBO J. 1996 Nov 01; 15(21):5965-75. PMID: 8918474; PMCID: PMC452383.
    73. Maiti S, Doskow J, Li S, Nhim RP, Lindsey JS, Wilkinson MF. The Pem homeobox gene. Androgen-dependent and -independent promoters and tissue-specific alternative RNA splicing. J Biol Chem. 1996 Jul 19; 271(29):17536-46. PMID: 8663309.
      View in: PubMed
    74. Carter MS, Doskow J, Morris P, Li S, Nhim RP, Sandstedt S, Wilkinson MF. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem. 1995 Dec 01; 270(48):28995-9003. PMID: 7499432.
      View in: PubMed
    75. Li S, Sun G, Budde RJ. Production and characterization of monoclonal antibodies against the recombinant p50csk protein tyrosine kinase: a tool for signal transduction research. Hybridoma. 1995 Aug; 14(4):341-6. PMID: 8522345.
      View in: PubMed
    76. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 6:10697-10711.
    77. Corrigendum to "Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells". Journal of Hepatology.
    78. The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant. International Reviews of Immunology.
    79. Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. Hepatology.
    80. Potential function of exogenous vimentin on the activation of Wnt signaling pathway in cancer cells. Journal of Cancer. 7:1824-1832.
    81. Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients. Scientific Reports. 6.
    82. Lack of immunomodulatory interleukin-27 enhances oncogenic properties of mutant p53 in vivo. Clinical Cancer Research. 22:3876-3883.
    83. Passive and active tumor homing cytokine therapy. 97-113.
    84. Erratum. Molecular Therapy. 20:1076.
    85. Targeted cancer immune therapy.
    86. Role of IL12 family in regulation of antitumor immune response. 3-18.
    87. Effects of ethephon on the respiration and ethylene evolution of sweet cherry (Prunus avium L.) fruit at different development stages. Postharvest Biology and Technology. 4:235-243.
    88. IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin. Oncotarget. 7:77138-77151.
    89. TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. Journal of Clinical Investigation. 126:527-542.
    90. Partial purification and characterization of β-D-galactosidase from sweet cherry, a nonclimacteric fruit. Journal of Agricultural and Food Chemistry. 42:2177-2182.
    91. Mutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomas. PLoS One. 11.
    92. Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells. Oncotarget. 7:72021-72032.
    93. IL-12-based therapy of malignancies. Drugs of Today. 37:629-637.
    94. Reply. Hepatology. 56:2425.
    95. Erratum. Biological Procedures Online. 18.
    96. Preface. Unknown Journal.
    97. Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance. OncoImmunology. 5.
    98. Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation. Scientific Reports. 6.
    99. Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics. 6:1004-1011.
    100. Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells. Biological Procedures Online. 16.
    101. Erratum. Cancer Gene Therapy. 17:826.
    102. Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells. Journal of Hepatology.
    103. T cell receptor mRNA regulation. FASEB Journal. 10.
    LI's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description